Sam Dustman

The 340B Drug Pricing Program continues to face challenges and opportunities as we head into the fall. Read on for details on recent…

Join us for a webinar providing an overview of the current 340B landscape, including compliance, manufacturer, and legislative updates.

The annual recertification window for FQHCs and most grantee-type entities opens January 30, 2023 and closes February 27, 2023. Read on for…

All 340B covered entities that submit claims for separately payable Part B drugs and biologicals face a new requirement starting January 1,…

The 340B Program faces ongoing challenges and opportunities as the year progresses. Read on for a recap of headlines that have emerged…

The U.S. Supreme Court has ruled that HHS wrongly lowered Medicare reimbursement rates for 340B outpatient drugs. Read on for more details.